Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Preclinical results with Ergo Science's neuroendocrine resetting therapy

Nov. 4, 1997

Sequana and Glaxo Wellcome revise diabetes/obesity alliance

Nov. 4, 1997

Pamidronate for preventing glucocorticoid-induced osteoporosis

Nov. 3, 1997

New neurotransmitter implicated in hunger and satiety

Oct. 31, 1997

Antiprogestational agents available from the NIH

Oct. 31, 1997

NIAID researchers report advances in gene therapy for CGD

Oct. 30, 1997

Niemann-Pick Type C disease-related technology available for licensing from NIH

Oct. 30, 1997

Beta3-adrenoceptor agonists reported by Asahi Chemical

Oct. 30, 1997

Pravachol now available in Canada for preventing a first heart attack

Oct. 29, 1997

New ACAT inhibitors discovered at Mitsubishi Chemical

Oct. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...